News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,474 Results
Type
Article (49670)
Company Profile (278)
Press Release (683526)
Section
Business (212258)
Career Advice (2098)
Deals (36533)
Drug Delivery (103)
Drug Development (83599)
Employer Resources (173)
FDA (16959)
Job Trends (15706)
News (359186)
Policy (34658)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2774)
Accelerated approval (2)
Adcomms (23)
Allergies (83)
Alliances (51544)
ALS (85)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (112)
Approvals (16956)
Artificial intelligence (247)
Autoimmune disease (14)
Automation (14)
Bankruptcy (373)
Best Places to Work (12097)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (191)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (257)
Cancer (2014)
Cardiovascular disease (157)
Career advice (1758)
Career pathing (30)
CAR-T (142)
Cell therapy (398)
Cervical cancer (19)
Clinical research (67576)
Collaboration (783)
Compensation (449)
Complete response letters (20)
COVID-19 (2708)
CRISPR (35)
C-suite (212)
Cystic fibrosis (99)
Data (1919)
Decentralized trials (2)
Denatured (26)
Depression (43)
Diabetes (248)
Diagnostics (6541)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (110)
Drug pricing (102)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (88263)
Editorial (34)
Employer branding (21)
Employer resources (147)
Events (116583)
Executive appointments (642)
FDA (18087)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (702)
Gene editing (98)
Generative AI (24)
Gene therapy (278)
GLP-1 (729)
Government (4648)
Grass and pollen (4)
Guidances (48)
Healthcare (19893)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (106)
Indications (27)
Infectious disease (2842)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (83)
Interviews (319)
IPO (16852)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (34)
Layoffs (466)
Leadership (16)
Legal (8454)
Liver cancer (73)
Lung cancer (296)
Lymphoma (130)
Machine learning (2)
Management (58)
Manufacturing (270)
MASH (62)
Medical device (14317)
Medtech (14322)
Mergers & acquisitions (20150)
Metabolic disorders (655)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (86)
Neuropsychiatric disorders (28)
Neuroscience (1889)
NextGen: Class of 2025 (6910)
Non-profit (4736)
Northern California (2403)
Now hiring (37)
Obesity (359)
Opinion (215)
Ovarian cancer (72)
Pain (80)
Pancreatic cancer (77)
Parkinson's disease (135)
Partnered (18)
Patents (202)
Patient recruitment (95)
Peanut (48)
People (59903)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21020)
Phase II (29693)
Phase III (22193)
Pipeline (969)
Podcasts (57)
Policy (110)
Postmarket research (2741)
Preclinical (8935)
Press Release (67)
Prostate cancer (94)
Psychedelics (32)
Radiopharmaceuticals (254)
Rare diseases (363)
Real estate (6297)
Recruiting (65)
Regulatory (23537)
Reports (46)
Research institute (2478)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (68)
Series A (121)
Series B (79)
Service/supplier (13)
Sickle cell disease (50)
Southern California (2082)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (13)
Supply chain (62)
The Weekly (28)
United States (21331)
Vaccines (691)
Venture capitalists (38)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (15)
Date
Today (3)
Last 7 days (575)
Last 30 days (2466)
Last 365 days (34301)
2025 (7842)
2024 (36110)
2023 (41150)
2022 (52383)
2021 (57104)
2020 (55914)
2019 (48797)
2018 (36938)
2017 (33752)
2016 (33572)
2015 (39620)
2014 (33327)
2013 (28559)
2012 (30852)
2011 (31556)
2010 (29929)
Location
Africa (793)
Alabama (50)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40855)
Australia (6733)
California (5499)
Canada (1866)
China (482)
Colorado (255)
Connecticut (272)
Delaware (126)
Europe (88456)
Florida (816)
Georgia (198)
Idaho (61)
Illinois (528)
India (23)
Indiana (295)
Iowa (9)
Japan (139)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (863)
Massachusetts (4180)
Michigan (214)
Minnesota (381)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (67)
New Jersey (1577)
New Mexico (29)
New York (1581)
North Carolina (974)
North Dakota (7)
Northern California (2403)
Ohio (192)
Oklahoma (14)
Oregon (34)
Pennsylvania (1246)
Puerto Rico (9)
Rhode Island (28)
South America (1183)
South Carolina (19)
South Dakota (1)
Southern California (2082)
Tennessee (94)
Texas (824)
Utah (167)
Virginia (132)
Washington D.C. (61)
Washington State (523)
West Virginia (3)
Wisconsin (49)
733,474 Results for "spectral medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spectral Medical Provides February Tigris Trial Update
March 3, 2025
·
3 min read
Press Releases
Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update
March 28, 2025
·
14 min read
Business
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced the results of its Annual Meeting of shareholders.
June 7, 2024
·
3 min read
Press Releases
Spectral Medical Provides January Tigris Trial Update
February 3, 2025
·
3 min read
Business
Spectral Medical Chair to Retire From the Board of Directors
Spectral Medical Inc. announced that Anthony Bihl III, Spectral’s Chairman, will be retiring from the Board at Spectral’s upcoming Shareholder Meeting in June 2024.
April 2, 2024
·
3 min read
Press Releases
Spectral Medical Provides December Tigris Trial Update
January 6, 2025
·
3 min read
Press Releases
Spectral Medical Provides November Tigris Trial Update
December 2, 2024
·
4 min read
Press Releases
Spectral AI Provides Update to Investors
January 22, 2025
·
4 min read
Business
Spectral Medical Announces First Quarter 2024 Results and Provides Corporate Update
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced its financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 13, 2024
·
13 min read
Spectral Medical Provides April 2024 Tigris Trial Update
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock.
May 6, 2024
·
3 min read
1 of 73,348
Next
